Citadel Advisors’s DS HEALTHCARE GROUP, INC. NEW COMMON STOCK DSKX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-16,872
Closed -$13K 8041
2016
Q1
$13K Buy
+16,872
New +$27.7K ﹤0.01% 6578
2015
Q2
Sell
-16,456
Closed -$13K 9546
2015
Q1
$13K Buy
+16,456
New +$13.3K ﹤0.01% 8142
2014
Q4
Sell
-16,302
Closed -$17K 9143
2014
Q3
$17K Buy
16,302
+5,789
+55% +$7.58K ﹤0.01% 7581
2014
Q2
$18K Sell
10,513
-1,556
-13% -$2.94K ﹤0.01% 7369
2014
Q1
$25K Buy
+12,069
New +$27.8K ﹤0.01% 7199

Other funds holding DSKX

Citadel Advisors's DSKX Position: Q2 2016 in Review

Citadel Advisors sold out of DS HEALTHCARE GROUP, INC. NEW COMMON STOCK (DSKX) in Q2 2016, closing a stake of 16,872 shares — an estimated $13K sold.

Citadel Advisors first reported a position in DSKX in Q1 2014 and held it in 5 quarters. The position peaked at $25K in Q1 2014. 17 funds tracked by Wall St. Rank hold DSKX as of Q2 2016.

  • Citadel Advisors reported no remaining DS HEALTHCARE GROUP, INC. NEW COMMON STOCK position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 16,872 DS HEALTHCARE GROUP, INC. NEW COMMON STOCK shares in Q2 2016, an estimated $13K.
  • Citadel Advisors first reported a position in DS HEALTHCARE GROUP, INC. NEW COMMON STOCK in Q1 2014 and held it in 5 quarters.
  • Citadel Advisors's DS HEALTHCARE GROUP, INC. NEW COMMON STOCK position peaked at $25K in Q1 2014.
  • 17 funds tracked by Wall St. Rank held DS HEALTHCARE GROUP, INC. NEW COMMON STOCK as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.